Cell movement through three-dimensional (3D) extracellular matrix (ECM) is an essential component of normal
physiology and disease, including wound healing and tumor metastasis. Understanding how cells move
through structurally diverse 3D matrices will be essential to design therapies aimed at controlling cell migration
in the body. During 3D migration, both metastatic tumor cells and wound healing fibroblasts are faced with the
same problem: how to efficiently move the bulky, stiff nucleus. While the power of actomyosin contractility is
essential for cells to move their nuclei in 3D matrices, it is not understood how it is regulated by the ECM
structure or coupled to the influx of water into the cells that is necessary to sustain high-pressure migration. An
additional layer of complexity comes from the fact that the 3D matrix structure can govern actomyosin
contractility to dictate the type of protrusions cells use to move (i.e. migratory plasticity). By understanding how
the structure of the 3D ECM affects actomyosin contractility and water influx, we aim to create a conceptual
framework to explain how and why human cells switch between distinct 3D migration mechanisms. We
recently discovered that human cells moving in a linearly elastic 3D matrix rely on integrin-based cell-matrix
adhesions and the power of actomyosin contractility to pull the nucleus forward, like a piston, and switch from
using low-pressure lamellipodia to high-pressure lobopodial protrusions. This project will explore how the cell
reprograms its intracellular architecture and polarity to power the nucleus, and thereby the cell through 3D
matrices. To achieve these goals, we will focus on three key gaps in knowledge. Question 1: how is the
nuclear piston pulling mechanism activated in response to the physical environment? While the nucleus can
act as a mechanosensor to control contractility at the rear of the cell, the mechanosensor that regulates the
pulling mechanism has not been identified. Question 2: How are organelles and endomembranes organized
and transported past the nucleus in compartmentalized, pressurized cells using the piston mechanism? This
question will help us understand how the secretion pathways identified addressing question 1 function in high-
pressure, compartmentalized cells. Question 3: Once activated, how is the anterior contractility responsible for
pulling the nucleus forward sustained over the hours to days that primary human fibroblasts sustain this mode
of 3D migration? While contractility at the trailing edge is well known to push the nucleus forward, very little is
understood about the longer-term regulation of the pulling forces generated by the piston mechanism. By
addressing these questions, our research will establish how distinct pools to actomyosin contractility are linked
to the control of cytoplasmic hydraulic pressure to achieve 3D motility. This enhanced understanding of the
fundamental principles of directional 3D cell motility and migratory plasticity will lead to new therapeutic
strategies to control normal and abnormal cell movement in the body.
Public Health Relevance Statement
Project Narrative
The movement of single cells through three-dimensional tissue environments is essential for
physiological processes like wound healing, but is a lethal characteristic of metastatic tumor cells.
The goal of this research project is to understand how cell behavior and architecture is
reprogrammed in response to the structure of the material they are moving through. This
information will help develop new therapeutic strategies to control the movement of normal and
abnormal cells in the body.
No Sub Projects information available for 1R35GM156335-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM156335-01
Patents
No Patents information available for 1R35GM156335-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM156335-01
Clinical Studies
No Clinical Studies information available for 1R35GM156335-01
News and More
Related News Releases
No news release information available for 1R35GM156335-01
History
No Historical information available for 1R35GM156335-01
Similar Projects
No Similar Projects information available for 1R35GM156335-01